MY204616A - Chromosome biomarker - Google Patents

Chromosome biomarker

Info

Publication number
MY204616A
MY204616A MYPI2021001896A MYPI2021001896A MY204616A MY 204616 A MY204616 A MY 204616A MY PI2021001896 A MYPI2021001896 A MY PI2021001896A MY PI2021001896 A MYPI2021001896 A MY PI2021001896A MY 204616 A MY204616 A MY 204616A
Authority
MY
Malaysia
Prior art keywords
chromosome
biomarker
analysing
physical performance
chromosome regions
Prior art date
Application number
MYPI2021001896A
Other languages
English (en)
Inventor
Alexandre Akoulitchev
Aroul Ramadass
Ewan Hunter
Original Assignee
Oxford BioDynamics PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1817181.9A external-priority patent/GB201817181D0/en
Priority claimed from GBGB1904066.6A external-priority patent/GB201904066D0/en
Application filed by Oxford BioDynamics PLC filed Critical Oxford BioDynamics PLC
Publication of MY204616A publication Critical patent/MY204616A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H15/00ICT specially adapted for medical reports, e.g. generation or transmission thereof
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/30ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/124Animal traits, i.e. production traits, including athletic performance or the like
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
MYPI2021001896A 2018-10-22 2019-10-21 Chromosome biomarker MY204616A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1817181.9A GB201817181D0 (en) 2018-10-22 2018-10-22 Chromosome biomarker
GBGB1904066.6A GB201904066D0 (en) 2019-03-25 2019-03-25 Chromosome biomarker
PCT/GB2019/052996 WO2020084289A1 (en) 2018-10-22 2019-10-21 Chromosome biomarker

Publications (1)

Publication Number Publication Date
MY204616A true MY204616A (en) 2024-09-05

Family

ID=68296533

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2021001896A MY204616A (en) 2018-10-22 2019-10-21 Chromosome biomarker

Country Status (13)

Country Link
US (1) US12584172B2 (https=)
EP (1) EP3870719A1 (https=)
JP (1) JP7599417B2 (https=)
KR (1) KR102901797B1 (https=)
CN (1) CN113366121A (https=)
AU (1) AU2019363806B2 (https=)
CA (1) CA3115024A1 (https=)
IL (1) IL282089B2 (https=)
MY (1) MY204616A (https=)
SG (1) SG11202103603VA (https=)
TW (1) TWI861021B (https=)
WO (1) WO2020084289A1 (https=)
ZA (1) ZA202102664B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220170766A (ko) 2021-06-22 2022-12-30 주식회사 엘지화학 단백질 키나아제 억제제로서의 신규한 화합물
GB202412610D0 (en) * 2024-08-28 2024-10-09 Oxford BioDynamics PLC Screening method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7998744B2 (en) 2008-07-28 2011-08-16 Greenwood Genetic Center, Inc. Methods for determining dysregulation of methylation of brain expressed genes on the X chromosome to diagnose autism spectrum disorders
WO2012106559A1 (en) 2011-02-02 2012-08-09 Translational Genomics Research Institute Biomarkers and methods of use thereof
US9284594B2 (en) 2013-07-23 2016-03-15 The Regents Of The University Of Michigan Compositions and methods relating to fusion protein biomarkers
JP2018527016A (ja) * 2015-06-24 2018-09-20 オックスフォード バイオダイナミックス リミテッド 染色体相互作用の検出
CN108359732A (zh) * 2017-01-25 2018-08-03 株式会社大熊制药 用于预测训练反应的生物标志物

Also Published As

Publication number Publication date
TWI861021B (zh) 2024-11-11
IL282089A (en) 2021-05-31
WO2020084289A1 (en) 2020-04-30
AU2019363806A1 (en) 2021-05-06
KR102901797B1 (ko) 2025-12-17
IL282089B2 (en) 2024-08-01
SG11202103603VA (en) 2021-05-28
CN113366121A (zh) 2021-09-07
KR20210080516A (ko) 2021-06-30
US20220282328A1 (en) 2022-09-08
ZA202102664B (en) 2022-10-26
CA3115024A1 (en) 2020-04-30
IL282089B1 (en) 2024-04-01
JP2022512842A (ja) 2022-02-07
JP7599417B2 (ja) 2024-12-13
AU2019363806B2 (en) 2022-03-31
EP3870719A1 (en) 2021-09-01
NZ775029A (en) 2025-03-28
US12584172B2 (en) 2026-03-24
TW202035704A (zh) 2020-10-01

Similar Documents

Publication Publication Date Title
EP3977547A4 (en) ELECTROCHEMICAL DEVICE
SA518390949B1 (ar) طريقة لتحديد المسامية المرتبطة بمادة عضوية في بئر أو تكوين
MX2019014497A (es) Metodo para producir celula eucariota de adn editado, y kit usado en el mismo.
CL2018001813A1 (es) Proceso de producción de litio integrado
GB201817166D0 (en) Multi-junction device production process
MX2016012387A (es) Sistema de medicion tridimensional para linea marcada para adherir suela a la parte superior y metodo de medicion tridimensional para el mismo.
MX2017003189A (es) Metodos de gestion de salud y bienestar y sistemas utiles para la practica de los mismos.
TW201613832A (en) Thin glass roll and method for producing same
EP3592845A4 (en) NK-92 HANK003 MODIFIED CELLS FOR THE CLINIC
WO2016023991A8 (de) Verfahren zur mikrobiom-analyse
MY200355A (en) Process for the manufacturing of methane sulfonic acid
WO2018146557A3 (en) Long double-stranded rna for rna interference
SE1751327A1 (en) System and method for optical inspection of an object
NZ730124A (en) A method of predicting risk of recurrence of cancer
ZA202102546B (en) Methods for identifying free thiols in proteins
EP4220178A3 (en) Quantitation of tamoxifen and metabolites thereof by mass spectrometry
MY173150A (en) A device for diffusing a compound
EA201891226A1 (ru) Способ сокращения общего потребления электроэнергии при производстве наноцеллюлозы
MY204616A (en) Chromosome biomarker
TW201614507A (en) Methods and devices for finding settings to be used in relation to a sensor unit connected to a processing unit
EP3765044A4 (en) TREATMENT METHODS FOR NON-CANCERIOUS DISORDERS USING HEMATOPOIETIC CELLS
SG11201805456WA (en) Modification method for sheet-shaped cell culture
IN2014CH00466A (https=)
EP4242625A3 (en) Method of determining strain limits
MX364291B (es) Metodo de codificacion de audio y aparato relacionado.